Content area


Effectiveness of propanolol for treatment of infantile haemangioma

Ida Gillberg Andersen¹, Catherine Rechnitzer² & Birgitte Charabi³ 1) Faculty of Health and Medical Sciences, University of Copenhagen 2) Department of Paediatrics and Adolescent Medicine, Rigshospitalet 3) Department of Otorhinolaryngology, Head and Neck Surgery, Rigshospitalet
INTRODUCTION Infantile haemangiomas (IH) are the most common benign tumours in children. They are characterised by rapid growth during the first year of life followed by spontaneous regression during childhood. Indications for treatment are functional impairment, bleeding/ulceration, rapid growth and severe aesthetic risk. Recently, systemic treatment with propranolol has become the first-line therapy. The objective of this study was to assess the efficacy of propranolol in the treatment of IH and to investigate whether treatment with a low dose of 1 mg/kg/day was sufficient. MATERIAL AND...
Blad nummer: 
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Mats Lindberg | 20/01
1 Kommentar
af Poul Erik Rørbæk | 20/01
4 kommentarer
af Kurt Håkonsson | 19/01
4 kommentarer
af Erik Kristensen | 17/01
20 kommentarer
af Thomas Michael Dan Aru | 17/01
4 kommentarer
af Claus Bo Svenningsen | 15/01
1 Kommentar
af Lars Kambjerre | 14/01
6 kommentarer